End-of-year final results for AMS were good. The share price jumped from about £1.10 to £1.18; this could be the stimulus the share needed as it been quiet this year so far. Personally, I’m going to wait for the next buy signal which, I accept, may mean missing a step up.

As a reminder, AMS is a medical technology company that sell advanced wound care products.

The Group operates mainly in the UK, the Netherlands, Germany, the Czech Republic and Russia, with a sales office located in the USA.

They are debt free and, founded in 1991; they employ 450.

Sales and net profit have increased nicely, and the profit margin is steady. However, administrative cost is high, slightly, as is inventory. They have a new Chairman, and the CEO sold a substantial amount of shares in AMS yesterday. So, I’m waiting and will, of course, let you know when a strong buy signal happens.